Carboplatin/Nab-Paclitaxel/Pembrolizumab Followed by Pembrolizumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carboplatin, nab-paclitaxel, and pembrolizumab followed by pembrolizumab that can be used for the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Abraxane/Carboplatin/Keytruda Followed by Keytruda - Carboplatin/Albumin-bound Paclitaxel/Pembrolizumab Followed by Pembrolizumab - Carboplatin/Nab-Paclitaxel/Pembrolizumab Followed by Pembrolizumab - Pembrolizumab Plus Albumin-bound Paclitaxel/Carboplatin Followed by Pembrolizumab